Automation-compatible prepared culture media plate technology6 Aug 2019
Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.
The launch of a robust, easy-to-handle, sustainable plate design for prepared culture media products in the US and Canada supports the latest automated and manual methods for the analysis of microbiological samples for clinical, food safety testing and pharmaceutical laboratories.
Fully compatible with all available automated specimen processors, the SmartPlate design brings together Thermo Scientific Oxoid and Thermo Scientific Remel prepared culture media with an enhanced universal plate format for efficient and high-throughput isolation, identification, differentiation and screening of samples. The innovative SmartPlate technology offers a sustainable assay plate design that reduces the resin materials used to manufacture each plate, as well as minimizing laboratory waste thanks to its advanced durability.
Thermo Fisher Scientific is showcasing its latest SmartPlate technology during the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019), being held August 4–8, on Booth #2110 at the Anaheim Convention Center, Anaheim, California.
"As clinical, food safety testing and pharmaceutical laboratories embrace the automation of routine analyses, scientists increasingly rely on prepared culture media plates to enable greater efficiency, while maintaining the highest levels of accuracy," said Bernd Hofmann, vice president of marketing, microbiology, Thermo Fisher Scientific. "The launch of the SmartPlate format brings together our proven Oxoid and Remel prepared culture media with a durable, universal plate design that is compatible with any specimen processor available on the market today, helping our customers deliver accurate results across both automated and manual methods."
The SmartPlate design harnesses unique stacking rings to enhance the stackability and ease-of-transport for a large number of sample plates in a single movement. This improves manual handling around the laboratory, between facilities and processing within automated-handling installations. By stacking the SmartPlate formats, laboratories can also maximize the valuable capacity of premium laboratory workspaces, including refrigerators and incubators.
Funding to accelerate delivery of Univercells' vaccine portfolio
11 Oct 2019
European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.Read more
Industrial-scale manufacture of therapeutic exosomes
10 Oct 2019
Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.Read more
BASF and Biomillenia join forces in microbiome research to promote healthy skin
7 Oct 2019
Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.Read more
Arctoris secures funding to advance novel robotic drug discovery platform
1 Oct 2019
Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,Read more
Data on lead ADC demonstrates effective tumour regression
1 Oct 2019
IKS01 shows marked anti-tumour efficacy in pre-clinical models of ovarian and lung cancer.Read more
Researchers develop less toxic anti-cancer drug
24 Sep 2019
New drug works like a ‘magic bullet’ that is delivered directly to the mitochondria of cancer cells.Read more
EC approves its first plant-derived cannabis-based medicine
24 Sep 2019
Epidyolex (cannabidiol) approved for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy.Read more
Study demonstrates potential of blood test for early lung cancer detection
16 Sep 2019
Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer.Read more
M2i Life Sciences completes a historic fundraising of 60 million Euros
16 Sep 2019
To support its strong growth, M2i Life Sciences has concluded a capital increase of 60 million Euros with five leading investors (ADM Capital, Eurazeo Growth, Téthys Invest, Creadev and France 2i fund managed by RAISE Impact).Read more
FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
10 Sep 2019
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation